A new trading day began on Tuesday, with Altimmune Inc (NASDAQ: ALT) stock price up 2.51% from the previous day of trading, before settling in for the closing price of $3.58. ALT’s price has ranged from $2.90 to $11.16 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 3.48% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 7.66%. With a float of $80.26 million, this company’s outstanding shares have now reached $81.11 million.
In an organization with 59 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -205.0%, operating margin of -490965.0%, and the pretax margin is -454605.0%.
Altimmune Inc (ALT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Altimmune Inc is 1.04%, while institutional ownership is 47.69%. The most recent insider transaction that took place on Mar 17 ’25, was worth 5,784. In this transaction Director of this company bought 1,000 shares at a rate of $5.78, taking the stock ownership to the 1,000 shares. Before that another transaction happened on Mar 13 ’25, when Company’s Chief Financial Officer bought 10,000 for $5.20, making the entire transaction worth $51,996. This insider now owns 10,000 shares in total.
Altimmune Inc (ALT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 7.66% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.73% during the next five years compared to 3.48% growth over the previous five years of trading.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Here are Altimmune Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 15.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14882.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.25, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.31 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Let’s dig in a bit further. During the last 5-days, its volume was 2.46 million. That was inferior than the volume of 3.82 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 7.57%.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 15.94%, which indicates a significant increase from 15.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.20 in the past 14 days, which was lower than the 0.38 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.05, while its 200-day Moving Average is $6.20.
